About
Altaf Jamil, MD, is a pediatric cancer doctor with board certifications in pediatrics and pediatric hematology and oncology. He has more than two decades of experience providing expert care for cancer in children, including leukemia, lymphoma, neuroblastoma, osteosarcoma, Ewing sarcoma and Wilms tumor. Dr. Jamil also offers specialized care for patients with bone marrow diseases like anemia, neutropenia and thrombocytopenia; hemophilia and other bleeding disorders and sickle cell disease.
Dr. Jamil is driven by a deep desire to make a meaningful impact on the lives of children and their families, and the resilience and courage of young patients facing serious illnesses like cancer inspired him to pursue a career in pediatric hematology and oncology. He is passionate about providing compassionate care, advancing medical research and working towards better outcomes for children with blood disorders and cancer. His care philosophy centers on providing holistic, patient-centered care that addresses not only the medical needs but also the emotional and psychological well-being of patients and their families.
In his spare time, Dr. Jamil is passionate about reading, particularly medical literature, and recharges by spending time outdoors cycling, playing cricket and soccer or spending time in nature with his family. He is married to a pediatric pulmonologist, and together they have three daughters and one son who keep them busy and entertained. The Jamil family also has a beloved pet cat who they try to keep away from the numerous bird feeders have set up outside their house.
Education & Training
Medical School
Khyber Medical College
Residency
Pediatrics
- Tod Children's Hospital Pediatric Residency
Pathology - Anatomic/Pathology - Clinical
- Mallory Institute Pathology Foundation
Fellowship
Pediatric Hematology-Oncology
- Nationwide Children's Hospital
Boards
Insurances
MU Health Care participates with most major managed care organizations. To find out whether MU Health Care is a participating provider in your insurance plan or network, or for information on co-payments and deductibles, please contact your insurance carrier directly.
Academic Information
Research Profile
Altaf Jamil, MD, is a board-certified pediatric hematologist-oncologist and researcher with more than two decades of experience diagnosing, managing and treating leukemia, lymphoma, solid tumor cancers including neuroblastoma and osteosarcoma, noncancerous bone marrow disease, sickle cell disease and bleeding disorders. He is a passionate clinician and researcher who seeks to improve care for patients and their families through clinical trials.
Dr. Jamil is a member of the Children’s Oncology Group (COG), a National Cancer Institute (NCI) backed organization that brings together more than 10,000 experts from 200 institutions around the globe with the goal of advancing cancer care for children. His research work includes extensive research on the TEL/AML-1 fusion gene, which has provided valuable insights into the pathogenesis and treatment of pediatric leukemia, as well as investigating familial hemophagocytic lymphohistiocytosis (fHLH), contributing to a better understanding of this rare but severe condition. Another key area of his research has been the innovation in the management of soft tissue sarcomas in infants and young children.
He is excited to join a team of physicians, researchers, advanced practice providers, nurses and support staff who share a commitment to cutting-edge research, comprehensive patient care and community outreach. Dr. Jamil is eager to collaborate with esteemed colleagues, contribute to groundbreaking research and provide exceptional care to young patients in the state of Missouri and beyond.
Research Interests
- Clinical trials
- Pediatric leukemia treatment
- Treatment of benign hematological conditions
Areas of Expertise
- Pediatric leukemia and lymphoma
- Pediatric bone marrow disease, including neutropenia, anemia and thrombocytopenia
- Sickle cell disease
- Hemophilia and bleeding disorders
- Pediatric solid tumors, including neuroblastoma, Ewing sarcoma, osteosarcoma and Wilms’
tumor - Clinical trials and research to advance treatments in pediatric hematology and oncology